Antitubercular Agents < Antiviral Agents < Anus Diseases

Facettes : Author.f AffPays.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 498.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000087 (2020)	Kamal Kant Sahu [Oman] ; Ajay Kumar Mishra [Oman] ; Amos Lal [Oman]	COVID-2019: update on epidemiology, disease spread and management.
000103 (2020)	Paolo Calligari [Italie] ; Sara Bobone [Italie] ; Giorgio Ricci [Italie] ; Alessio Bocedi [Italie]	Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs.
000157 (2020)	Yung-Fang Tu [Taïwan] ; Chian-Shiu Chien [Taïwan] ; Aliaksandr A. Yarmishyn [Taïwan] ; Yi-Ying Lin [Taïwan] ; Yung-Hung Luo [Taïwan] ; Yi-Tsung Lin [Taïwan] ; Wei-Yi Lai [Taïwan] ; De-Ming Yang [Taïwan] ; Shih-Jie Chou [Taïwan] ; Yi-Ping Yang [Taïwan] ; Mong-Lien Wang [Taïwan] ; Shih-Hwa Chiou [Taïwan]	A Review of SARS-CoV-2 and the Ongoing Clinical Trials.
000220 (2020)	Valentina Spezzani [Italie] ; Alessio Piunno [Italie] ; Hans-Ulrich Iselin [Suisse]	Benign COVID-19 in an immunocompromised cancer patient -  the case of a married couple.
000255 (2020)	Catherine S. Adamson [Royaume-Uni]	Antiviral Agents: Discovery to Resistance.
000280 (2020)	Claudia Cava [Italie] ; Gloria Bertoli [Italie] ; Isabella Castiglioni [Italie]	In Silico Discovery of Candidate Drugs against Covid-19.
000338 (2020)	Md Insiat Islam Rabby [Malaisie]	Current Drugs with Potential for Treatment of COVID-19: A Literature Review.
000440 (2020)	Yuefei Jin [République populaire de Chine] ; Haiyan Yang [République populaire de Chine] ; Wangquan Ji [République populaire de Chine] ; Weidong Wu [République populaire de Chine] ; Shuaiyin Chen [République populaire de Chine] ; Weiguo Zhang [République populaire de Chine] ; Guangcai Duan [République populaire de Chine]	Virology, Epidemiology, Pathogenesis, and Control of COVID-19.
000461 (2020)	Ye Yi [République populaire de Chine] ; Philip N P. Lagniton [République populaire de Chine] ; Sen Ye [République populaire de Chine] ; Enqin Li [République populaire de Chine] ; Ren-He Xu [République populaire de Chine]	COVID-19: what has been learned and to be learned about the novel coronavirus disease.
000464 (2020)	Guangyu Zhou [République populaire de Chine] ; Qi Zhao [République populaire de Chine]	Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2.
000505 (2020)	Sean Ekins [États-Unis] ; Thomas R. Lane [États-Unis] ; Peter B. Madrid [États-Unis]	Tilorone: a Broad-Spectrum Antiviral Invented in the USA and Commercialized in Russia and beyond.
000523 (2020)	Taisheng Li [République populaire de Chine] ; Hongzhou Lu [République populaire de Chine] ; Wenhong Zhang [République populaire de Chine]	Clinical observation and management of COVID-19 patients.
000582 (2020)	Mirko Baglivo [Italie] ; Manuela Baronio [Italie] ; Giuseppe Natalini [Italie] ; Tommaso Beccari [Italie] ; Pietro Chiurazzi [Italie] ; Ezio Fulcheri [Italie] ; Paolo Pietro Petralia [Italie] ; Sandro Michelini [Italie] ; Giovanni Fiorentini [Italie] ; Giacinto Abele Miggiano [Italie] ; Assunta Morresi [Italie] ; Gerolamo Tonini [Italie] ; Matteo Bertelli [Italie]	Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity?
000642 (2020)	H. Li [République populaire de Chine] ; Y M Wang [République populaire de Chine] ; J Y Xu [République populaire de Chine] ; B. Cao [République populaire de Chine]	[Potential antiviral therapeutics for 2019 Novel Coronavirus].
000671 (2020)	Liying Dong [République populaire de Chine] ; Shasha Hu [République populaire de Chine] ; Jianjun Gao [République populaire de Chine]	Discovering drugs to treat coronavirus disease 2019 (COVID-19).
000702 (2020)	Guangdi Li ; Erik De Clercq	Therapeutic options for the 2019 novel coronavirus (2019-nCoV).
000717 (2020)	Abdo A. Elfiky [Arabie saoudite]	Anti-HCV, nucleotide inhibitors, repurposing against COVID-19.
000752 (2020)	Kaijin Xu [République populaire de Chine] ; Hongliu Cai [République populaire de Chine] ; Yihong Shen [République populaire de Chine] ; Qin Ni [République populaire de Chine] ; Yu Chen [République populaire de Chine] ; Shaohua Hu [République populaire de Chine] ; Jianping Li [République populaire de Chine] ; Huafen Wang [République populaire de Chine] ; Liang Yu [République populaire de Chine] ; He Huang [République populaire de Chine] ; Yunqing Qiu [République populaire de Chine] ; Guoqing Wei [République populaire de Chine] ; Qiang Fang [République populaire de Chine] ; Jianying Zhou [République populaire de Chine] ; Jifang Sheng [République populaire de Chine] ; Tingbo Liang [République populaire de Chine] ; Lanjuan Li [République populaire de Chine]	[Management of corona virus disease-19 (COVID-19): the Zhejiang experience].
000754 (2020)	Calvin J. Gordon [Canada] ; Egor P. Tchesnokov [Canada] ; Joy Y. Feng [États-Unis] ; Danielle P. Porter [États-Unis] ; Matthias Götte [Canada]	The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus.
000763 (2020)	Jin-Yan Li [République populaire de Chine] ; Zhi You [République populaire de Chine] ; Qiong Wang [République populaire de Chine] ; Zhi-Jian Zhou [République populaire de Chine] ; Ye Qiu [République populaire de Chine] ; Rui Luo [République populaire de Chine] ; Xing-Yi Ge [République populaire de Chine]	The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future.
000795 (2020)	Emmie De Wit [États-Unis] ; Friederike Feldmann [États-Unis] ; Jacqueline Cronin [États-Unis] ; Robert Jordan [États-Unis] ; Atsushi Okumura [États-Unis] ; Tina Thomas [États-Unis] ; Dana Scott [États-Unis] ; Tomas Cihlar [États-Unis] ; Heinz Feldmann [États-Unis]	Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i -k "Antiviral Agents" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i  \
                -Sk "Antiviral Agents" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Antiviral Agents
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021